Abstract
(Abstracted from Am J Obstet Gynecol 2023;228(1):80.e1–80.e6) The use of antenatal corticosteroids (ACSs) is standard practice for women who are at risk of preterm birth to accelerate the development of vital organs, in particular the fetal lungs. Previous research has shown the efficacy of this treatment and its benefits in infants who are born preterm, but there is little research on the effects of ACS on infants who are subsequently born at term.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
